Do Antidepressants Kill Your Sex Drive? What to Do About Sexual Side Effects of SSRIs

Do Antidepressants Kill Your Sex Drive? What to Do About Sexual Side Effects of SSRIs

Clinical note: This blog is for informational purposes only and does not constitute medical advice. Do not stop, reduce, or change your antidepressant medication without first speaking with the prescribing physician or psychiatrist. The options described below are well-documented in the clinical literature and worth discussing with your provider. They are not recommendations to act on independently.

You started antidepressants and they worked. The weight of depression lifted. Anxiety became manageable. You could function again in ways that had felt out of reach. And then you noticed something else: your interest in sex had quietly disappeared. Or arousal had become difficult. Or orgasm, once reliable, now felt distant or absent entirely.

If this is your experience, you are in a large company. Sexual side effects are among the most common reasons people stop taking antidepressants before they are clinically ready to do so, and one of the most underreported concerns in psychiatry. Many people assume the trade-off is inevitable. Many others feel too embarrassed to bring it up with the prescriber who manages their medication. And so they live with it, in silence, while something important to their wellbeing and their relationships quietly erodes.

There is a lot more that can be done than most people realize. Understanding what is happening physiologically, what options exist medically, and how sex therapy fits into the picture gives you a much more complete set of tools than most providers offer in a standard appointment.

How Common Is This, Really?

Sexual dysfunction caused by SSRIs and related antidepressants is strikingly prevalent, and the figures are higher than most people expect. A 2024 study found over 88% of female patients and over 84% of male patients reported sexual dysfunction while taking antidepressants, with the highest rates among those on SSRIs and SNRIs. A 2025 narrative review confirmed sexual side effects affect a significant majority of people on serotonergic medications and are a leading driver of medication non-adherence. In other words, many people are quietly stopping medication that is helping their mental health because nobody has adequately addressed what it is doing to their sexual wellbeing.

The specific side effects vary between individuals and between medications, but the most commonly reported include reduced sexual desire, difficulty with arousal, delayed or absent orgasm, and in men, erectile difficulties. These effects are not a sign that something is uniquely wrong with your body. They are a pharmacological consequence that is predictable, documented, and in most cases addressable.

Why SSRIs Affect Sexual Desire and Function

To understand why SSRIs create sexual side effects, it helps to understand what they do. SSRIs work by increasing the availability of serotonin in the brain, which is what makes them effective for depression and anxiety. The problem is that serotonin has an inhibitory effect on sexual function through several mechanisms.

A 2024 review summarized the primary mechanisms: SSRIs activate serotonin receptors that suppress dopamine release, and dopamine is central to sexual motivation and desire. SSRIs also suppress nitric oxide, which is involved in genital arousal and erection, and can elevate prolactin levels, which further dampens libido. The result is a medication that treats the mind and simultaneously applies a brake to the biological systems that generate sexual interest and response.

This is not a character flaw or a sign that you are not attracted to your partner. It is a pharmacological effect operating at a neurochemical level that has nothing to do with how you feel about the people in your life or your inherent capacity for desire.

It is also worth distinguishing SSRI-induced sexual side effects from the sexual effects of depression itself. Depression independently suppresses libido, often significantly. Some people starting antidepressants find their sexual function improves as their mood lifts. For others, the medication addresses depression while simultaneously creating a new layer of sexual difficulty. Understanding the impact of your medication in addition to hormones and low libido can help you identify which factor is doing what matters for choosing the right response.

What You Can Discuss With Your Prescriber

Several well-documented medical approaches exist for managing antidepressant-induced sexual dysfunction. These are conversations to have with your prescribing physician or psychiatrist, not decisions to make unilaterally. The options below are included so you can walk into that conversation informed.

•  Dose reduction. Sexual side effects from SSRIs are dose-dependent in many cases. A 2024 review of the literature found dose reduction by 50% led to meaningful improvement in sexual function in the majority of patients studied, and that complete discontinuation after full remission resolved the side effects entirely in those cases. Whether dose reduction is appropriate depends on the stability of your mental health and is a clinical decision your prescriber needs to make with you.

•  Switching to a lower-risk antidepressant. Not all antidepressants carry the same sexual side effect burden. Bupropion (Wellbutrin) works via dopamine and norepinephrine rather than serotonin and is consistently associated with fewer sexual side effects, sometimes with improvement in desire. Mirtazapine is another option with a more favorable sexual side effect profile. Switching is not always straightforward, and the clinical benefit of the current medication needs to be weighed carefully, but it is a legitimate and frequently successful strategy.

•  Drug holidays. Some clinicians recommend planned short breaks from SSRIs with shorter half-lives on weekends, when sexual activity is more likely. The evidence for this approach is mixed and it carries some risks. It is worth discussing but not appropriate for all medications or all patients.

•  Adjunctive medications. PDE5 inhibitors such as sildenafil have been studied as adjunctive treatments for SSRI-induced erectile dysfunction with some evidence of benefit in men. Bupropion added to an SSRI regimen has also shown promise for improving desire in both men and women. These decisions belong with your prescriber.

What Sex Therapy and Psychological Support Offer

Medical management addresses the pharmacological dimension. What it cannot address is the psychological and relational impact of months or years of sexual difficulty: the shame that builds when your body stops responding, the distance that can develop between partners, the anxiety that now surrounds sexual encounters, or the disconnection from your own sense of yourself as a sexual person.

Psychological intervention has its own evidence base here. A 2025 study tested online CBT and mindfulness-based therapy programs against a waitlist control for women with sexual interest and arousal disorder and found both interventions produced significant improvements in sexual desire, arousal, and distress at post-treatment and at six-month follow-up. While this trial focused on sexual interest and arousal disorder broadly rather than SSRI-induced dysfunction specifically, the mechanisms at work, addressing self-consciousness, rumination, body disconnection, and avoidance, are directly relevant to the psychological sequelae of medication-induced sexual side effects.

In practice, sex therapy for SSRI-related sexual difficulties may involve:

•  Psychoeducation. Understanding the mechanism clearly, including that this is pharmacological rather than personal, reduces shame and interrupts the self-critical narrative that many people develop around it. Sometimes naming the mechanism accurately is itself therapeutic.

•  Addressing performance anxiety. Once sexual difficulties become established, anticipatory anxiety about whether things will work often develops as a secondary layer. This anxiety is itself a meaningful inhibitor of arousal and response, and it does not resolve simply because the medication side effect is managed. It needs direct attention.

•  Mindfulness-based approaches. SSRI side effects can create a disconnection from physical sensation that extends beyond arousal to a general sense of physical numbness or detachment. Mindfulness practices that rebuild present-moment body awareness can help restore access to sensation and pleasure, even when arousal response is still pharmacologically blunted.

•  Couples work. Partners are often affected by medication-induced sexual changes without fully understanding what is causing them. This creates misreads, hurt feelings, and relational distance that do not resolve on their own. Including a partner in some of the therapeutic work, with appropriate framing, can significantly shift the relational climate around sex.

•  Exploring responsive desire. People who tend to experience responsive sexual desire may find that SSRI side effects push their experience further in that direction, making the absence of spontaneous desire feel more alarming than it needs to. Understanding that desire can be contextually generated, not just spontaneously felt, opens up different approaches to maintaining a sexual relationship while on medication.

When Side Effects Persist After Stopping Medication

A smaller but clinically significant number of people experience sexual side effects that continue after discontinuing SSRIs. This condition, known as Post-SSRI Sexual Dysfunction (PSSD), is characterized by persistent genital numbness, reduced or absent orgasm, loss of libido, and in some cases emotional blunting. A 2024 paper highlighted PSSD as a genuine and under-recognized clinical phenomenon, noting significant barriers to accurate prevalence estimates due to underreporting and methodological inconsistency. If you have discontinued an SSRI and are still experiencing sexual dysfunction several months later, this is worth raising directly with a physician and a sex therapist who is familiar with the condition.

PSSD is not fully understood, and treatment options are limited and still being researched. Psychological support remains relevant for managing the distress, relational impact, and identity effects of the condition while the medical picture continues to develop.

You Do Not Have to Choose Between Your Mental Health and Your Sexual Wellbeing

The belief that you must simply accept sexual side effects as the cost of treating your mental health is neither accurate nor inevitable. There are documented options on the medical side. There is meaningful support available on the psychological and relational side and the two work best in combination.

The most important first step is talking about it, with your prescriber about the medical dimensions, and with an experienced sex therapist about everything the medication has created in your relationship with your body, your partner, and your own sexuality.

At Embrace Sexual Wellness, our Chicago-based sex therapists work regularly with individuals and couples navigating medication-related sexual changes. We bring clinical knowledge, genuine warmth, and a collaborative approach that works alongside your medical team rather than in isolation from it.

If antidepressants have affected your sex life and you are ready to address it, we invite you to schedule a free 10-minute phone consultation today!